UNOREADY Trademark

Trademark Overview

On Wednesday, May 15, 2019, a trademark application was filed for UNOREADY with the United States Patent and Trademark Office. The USPTO has given the UNOREADY trademark a serial number of 79263085. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, July 29, 2025. This trademark is owned by Novartis AG. The UNOREADY trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery devices, namely, injection devices for pharmaceuticals, injection devices for administering drugs
unoready

General Information

Serial Number79263085
Word MarkUNOREADY
Filing DateWednesday, May 15, 2019
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, July 29, 2025
Registration Number5947024
Registration DateTuesday, December 31, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2019

Trademark Statements

Goods and ServicesDrug delivery devices, namely, injection devices for pharmaceuticals, injection devices for administering drugs

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, July 19, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressBasel 4002
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Thursday, July 25, 2019ASSIGNED TO EXAMINER
Thursday, July 18, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 23, 2019APPLICATION FILING RECEIPT MAILED
Thursday, July 25, 2019NON-FINAL ACTION WRITTEN
Friday, July 26, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, August 17, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, August 20, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 27, 2019ASSIGNED TO LIE
Tuesday, August 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 27, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 31, 2019ATTORNEY REVIEW COMPLETED
Monday, September 9, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 25, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 25, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, December 31, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, April 28, 2020IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Friday, May 15, 2020IRREGULARITY FROM IB EXAMINED BY MPU
Saturday, October 12, 2019NOTIFICATION PROCESSED BY IB
Tuesday, October 15, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, April 16, 2020FINAL DISPOSITION PROCESSED
Thursday, April 16, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 15, 2020GENERIC MADRID TRANSACTION CREATED
Friday, July 3, 2020NOTIFICATION PROCESSED BY IB
Tuesday, July 29, 2025REGISTERED-SEC.71 ACCEPTED
Tuesday, July 29, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, May 12, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 15, 2020GENERIC MADRID TRANSACTION SENT TO IB
Sunday, October 11, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, December 31, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, January 13, 2025TEAS SECTION 71 RECEIVED

Related Keywords

unoready devices injection administering pharmaceuticals drugs namely delivery drug